title: Nicardipine and propranolol in the treatment of essential hypertension.
abstract: Two hundred thirty-four patients with supine diastolic blood pressure of between 95 and 114 mm Hg were enrolled into a double-blind, randomized, parallel, multicenter trial. The patients were randomized to either nicardipine 30 mg tid, propranolol 40 mg tid, or nicardipine 30 mg tid and propranolol 40 mg tid for six weeks. Two hundred six patients yielded data for analyses. Of the 28 not included, seven had missing data, whereas the remaining 21 were excluded because they either failed to meet inclusion criteria or were noncompliant at endpoint. Both nicardipine and propranolol as monotherapies and in combination achieved statistically significant, (P less than .01), supine diastolic blood pressure reduction relative to baseline. The combination of nicardipine and propranolol showed a greater reduction in supine diastolic and systolic measurements than either of the monotherapies. Nicardipine produced greater blood pressure reductions one hour after dosing, whereas the propranolol treatment tended to produce slightly greater blood pressure decreases eight hours after dose. The combination always resulted in the greatest blood pressure reduction, independent of time after dose. Adverse experiences were reported by 26% of patients in the nicardipine-treated group, most often transient vasodilatory effects, by 17% of the propranolol-treated patients, and by 18% of the combination-treated group. This study demonstrated at the doses studied that nicardipine alone produced equivalent blood pressure reductions to those obtained by propranolol alone, but that the combination of these two drugs produced greater reductions in blood pressures than either of the monotherapies.
authors.affiliation: Institute of Clinical Medicine, Syntex Research, Palo Alto, CA 94303.
authors.forename: J N
authors.initials: JN
authors.lastname: Lessem
authors.forename: E J
authors.initials: EJ
authors.lastname: Barone
authors.forename: T
authors.initials: T
authors.lastname: Berl
authors.forename: J
authors.initials: J
authors.lastname: Detwiler
authors.forename: A T
authors.initials: AT
authors.lastname: Lewin
authors.forename: G D
authors.initials: GD
authors.lastname: Lubash
authors.forename: R
authors.initials: R
authors.lastname: Margolis
authors.forename: R L
authors.initials: RL
authors.lastname: McGowan
authors.forename: C V
authors.initials: CV
authors.lastname: Ram
authors.forename: N
authors.initials: N
authors.lastname: Vlachakis
mesh_terms: D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009529:Nicardipine / Q000008:administration & dosage / Q000627:therapeutic use*; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use*; D011897:Random Allocation
chemical_list: D011433:Propranolol; D009529:Nicardipine